The American Association for the Study of Liver Diseases (AASLD) announced that an update to the Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 has been published in Hepatology.
The Guidance includes a summary of recommendations regarding treatment of hepatitis C virus (HCV) infection with direct-acting antiviral drugs. For each treatment option, recommendations reflect the best possible management for the patient and point of disease progression. The recommendations are rated based on the level of the evidence and strength of the recommendation. The original consensus recommendations address:
- HCV testing details and linkage to care
- Recommendations for initial treatment of HCV infection in patients starting treatment
- Retreatment information in persons for whom prior therapy has failed
- Unique patient populations data
The Guidance was created in partnership with the Infectious Diseases Society of America (IDSA) and in collaboration with the International Antiviral Society-USA (IAS-USA).
For more information visit HCVGuidelines.org.